CEO of company that makes miracle Alzheimer’s-drug-gone-wrong resigns

The chief executive of the drug company that created one of the most controversial drugs in the history of FDA approval is resigning, according to reports. Michael Vounatsos presided over Biogen during a rocky time during which the company halted, as a failure, studies on the Alzheimer’s drug aducanumab (Aduhelm); convinced the FDA to approve […]

Share DeepPol